Suchergebnisse - "Müller-Ide, Hendrik"

PubPharm (5)

1

Hepatobiliary long-term consequences of COVID-19 : dramatically increased rate of secondary sclerosing cholangitis in critically ill COVID-19 patients

enthalten in: Hepatology international | 2023

von Leonhardt, S. | Jürgensen, C. | Frohme, J. | +105

CommentIn: Hepatol Int. 2024 Mar 13;:. - PMID 38472608

2

Hepatobiliary long-term consequences of COVID-19: dramatically increased rate of secondary sclerosing cholangitis in critically ill COVID-19 patients

enthalten in: Hepatology international | 2023

von Leonhardt, S. | Jürgensen, C. | Frohme, J. | +19

3

Ritonavir, nelfinavir, saquinavir and lopinavir induce proteotoxic stress in acute myeloid leukemia cells and sensitize them for proteasome inhibitor treatment at low micromolar drug concentrations

enthalten in: Leukemia research | 2014

von Kraus, M. | Müller-Ide, H. | Rückrich, T. | +3

4

Ritonavir, nelfinavir, saquinavir and lopinavir induce proteotoxic stress in acute myeloid leukemia cells and sensitize them for proteasome inhibitor treatment at low micromolar drug concentrations

enthalten in: Leukemia research | 2014

von Kraus, M. | Müller-Ide, H. | Rückrich, T. | +3

5

Identifikation des HIV-Proteaseinhibitors Ritonavir als Medikament mit potentieller Wirksamkeit in der Therapie der Akuten Myeloischen Leukämie in Kombination mit Proteasominhibitoren

Erschienen: 2012

von Müller-Ide, H.

1
[1]